Cellular and viral microRNAs (miRNAs) are the transcriptional products of RNA polymerase II and are regulated by transcriptional factors for their differential expression. The altered expression of miRNAs in many cancer types has been explored as a marker for possible diagnosis and therapy. We report in this study that oncogenic human papillomaviruses (HPVs) induce aberrant expression of many cellular miRNAs and that HPV18 infection produces no detectable viral miRNA. Thirteen abundant host miRNAs were specifically regulated by HPV16 and HPV18 in organotypic raft cultures of foreskin and vaginal keratinocytes as determined by miRNA array in combination with small RNA sequencing. The increase of miR-16, miR-25, miR-92a, and miR-378 and the decrease of miR-22, miR-27a, miR-29a, and miR-100 could be attributed to viral oncoprotein E6, E7, or both, all of which are known to target many cellular transcription factors. The examination of 158 cervical specimens, including 38 normal, 52 cervical intraepithelial neoplasia (CIN), and 68 cervical cancer (CC) tissues, for the expression of these eight miRNAs showed a remarkable increase of miR-25, miR-92a, and miR-378 with lesion progression but no obvious change of miR-22, miR-29a, and miR-100 among the HPV-infected tissues. Further analyses indicate that an expression ratio ≥1.5 of miR-25/92a group over miR-22/29a group could serve as a cutoff value to distinguish normal cervix from CIN and from CIN to CC.
Cellular and viral microRNAs (miRNAs) are the transcriptional products of RNA polymerase II and are regulated by transcriptional factors for their differential expression. The altered expression of miRNAs in many cancer types has been explored as a marker for possible diagnosis and therapy. We report in this study that oncogenic human papillomaviruses (HPVs) induce aberrant expression of many cellular miRNAs and that HPV18 infection produces no detectable viral miRNA. Thirteen abundant host miRNAs were specifically regulated by HPV16 and HPV18 in organotypic raft cultures of foreskin and vaginal keratinocytes as determined by miRNA array in combination with small RNA sequencing. The increase of miR-16, miR-25, miR-92a, and miR-378 and the decrease of miR-22, miR-27a, miR-29a, and miR-100 could be attributed to viral oncoprotein E6, E7, or both, all of which are known to target many cellular transcription factors. The examination of 158 cervical specimens, including 38 normal, 52 cervical intraepithelial neoplasia (CIN), and 68 cervical cancer (CC) tissues, for the expression of these eight miRNAs showed a remarkable increase of miR-25, miR-92a, and miR-378 with lesion progression but no obvious change of miR-22, miR-29a, and miR-100 among the HPV-infected tissues. Further analyses indicate that an expression ratio ≥1.5 of miR-25/92a group over miR-22/29a group could serve as a cutoff value to distinguish normal cervix from CIN and from CIN to CC.
oncogenes E6 and E7 | noncoding RNAs | regulatory RNAs | virol oncogenesis | DNA tumor viruses C ervical cancer (CC) is the second most common cancer among women worldwide and is caused by persistent infection with oncogenic human papillomaviruses (HPVs). HPV infection has also been identified as a definitive human carcinogen for the penis, vulva, vagina, anus, and oropharynx (including the base of the tongue and tonsils) (1, 2) . To date, 15 mucosal HPV types are deemed as oncogenic or high-risk (HR) HPVs, including HPV16, HPV18, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV56, HPV58, HPV59, HPV68, HPV73, and HPV82 (3) . Among the HR HPVs, HPV16 and HPV18 have a combined worldwide contribution to ∼70% of invasive CC (4) .
The productive HPV life cycle is tightly linked to squamous cell differentiation, and organotypic raft cultures have been developed to grow these viruses in vitro (5) (6) (7) . HPV infection is initiated when viral particles gain entry to undifferentiated basal epithelial cells through an abrasion or a wound, where viral early genes are up-regulated during wound healing. The virus-aided expansion of the infected cell population then establishes the infection. The amplification of the extrachromosomal viral DNA and the expression of viral capsid proteins occur sequentially in the middle and upper spinous and superficial cells (7) . Persistent, active infection by HR HPVs can lead to cervical intraepithelial neoplasia (CIN) grade 1, 2, or 3 on the basis of increasing abnormal depths of the proliferative cell compartment in the cervical epithelium (8) . Histologically, the abnormal proliferative cells are restricted to the lower one-third of the epithelium in CIN1. CIN2 and CIN3 are distinguished by the expansion of the neoplasia to the lower two-thirds (CIN2) or more (CIN3) of the epithelium. CIN3 may involve the full thickness of the epithelium and is sometimes referred to as cervical carcinoma in situ. CIN2 and CIN3 are developed in 10-20% of women with CIN1, and a fraction of CIN3 may progress to CC when the neoplasia invades into the stroma underneath. Two viral oncoproteins, E6 and E7, of the HR HPVs destabilize, respectively, two major cellular tumor suppressor proteins, p53 and retinoblastoma protein (pRB). Both viral proteins function to support the productive phase of the infection in the postmitotic differentiated spinous cells. However, repeated elevated expression of HR HPV E6 and E7 in the undifferentiated basal epithelial cells or stem cells disrupts cell cycle regulation, inhibits cell differentiation, induces chromosome damage, and prevents apoptosis, resulting in cell immortalization and transformation, the basis of HPV carcinogenesis (9, 10) . Indeed, the expression of the HR HPV E6 and E7 is consistently elevated in CC.
MicroRNAs (miRNAs), noncoding regulatory RNAs with a length of ∼21 nt, are derived from RNA polymerase II transcripts of coding or noncoding genes, and their expression is subjected to transcriptional and posttranscriptional regulation.
Significance
Persistent infections with high-risk human papillomaviruses (HPVs) lead to development of cervical, penile, anal, and oropharyngeal cancers. The ability to diagnose HPV infections has been dependent on the detection of viral DNA, on virusassociated cytological and histological abnormalities, and on a few virus-induced host proteins. In this study, we identified a subset of host microRNAs regulated specifically by HPV16 or HPV18 infection in in vitro model systems. The elevated expression of miR-16, miR-25, miR-92a, and miR-378 and the decreased expression of miR-22, miR-27a, miR-29a, and miR-100 were attributed to viral oncoprotein E6 or E7. An expression ratio ≥1.5 of miR-25/92a group over miR-22/29a group was found to be informative in distinguishing normal cervix from cervical intraepithelial neoplasia and cervical cancers.
Argonaute proteins, the core components of the RNA-induced silencing complex, bind the mature miRNAs and guide them to imperfect complementary sequences located primarily in the 3′ UTR of target mRNAs, leading to translational repression or target degradation (11, 12) . The human genome encodes ∼550 miRNA genes to express about 1,000 miRNAs. miRNAs are differentially expressed in many human cell types (13) and target about 60% of genes (14) . Aberrant expression of miRNAs has been implicated in numerous disease states and has been explored as a biomarker for possible diagnosis or prognosis of human diseases (15) (16) (17) . Previously, our group and others found that HPV infection regulates the expression of keratinocyte miRNAs (18) (19) (20) and that aberrant miRNA expression in CC and its derived cell lines is important for cancer cell proliferation (21) (22) (23) (24) . However, the different approaches used led to varied observations (25, 26) . To date, there is no systematic study to identify host miRNAs as specific biomarkers for diagnosis of HPV infection or progression. In this report, by using miRNA array analysis and small RNA sequencing (miRNA-Seq), we conducted a comprehensive examination of miRNA profiles in human foreskin keratinocyte (HFK)-or human vaginal keratinocyte (HVK)-derived raft cultures with or without productive HPV16 or HPV18 infection. We identified a group of host miRNAs that are regulated by HPV18 E6 or E7. Altered expression of a subset of these miRNAs was also observed in HR HPV-infected CIN and CC tissues and may serve as a biomarker for HPV infection or progression.
Results

HPV16 and HPV18 Infection Regulates the Expression of a Subset of
Host miRNAs. To investigate HPV infection-induced genome-wide changes in miRNA expression, we first compared miRNA expression profiles in HFK-derived raft cultures with or without HPV16 infection by miRNA array analysis (Fig. S1 ). As shown in Fig. 1A (Left, panel 1), HPV16 infection led to decreased expression of 20 host miRNAs (green), including miR-34a (18) , and increased expression of 22 host miRNAs (red) (P < 0.05), including miR-16 (25) . Northern blot analysis of miR-181a, miR-455-3p, miR-203, miR-375, and miR-16 confirmed the altered expression (Fig. 1B, Upper) . To minimize potential experimental variances due to cell types, virus types, or detection methods, we expanded the investigation to HPV18 infection in two types of cells by using two analytical approaches. After initial verification by Northern blotting of altered expression of miR-100 and miR-378 in HFK-derived raft cultures with HPV18 infection (Fig. 2B , Lower), we further compared miRNA expression profiles in HFK-and HVK-derived raft cultures with or without HPV18 infection by using miRNA array analysis and miRNA-Seq (Fig.  1A , Right, panels 1-3). Although each cell type with or without HPV infection displayed a slightly different expression profile of host miRNAs (Fig. 1A and Tables S1-S4), 13 abundant host miRNAs with altered expression were commonly detected by both methods from raft cultures of HVKs or HFKs after HPV16 or HPV18 infection (Fig. 1C) . Eight miRNAs had increased expression, and five miRNAs had decreased expression (Table  1) . We confirmed by Northern blotting the altered expression of miR-16, miR-25, miR-22, and miR-29 in HVK-derived raft tissues infected with either HPV16 or HPV18 (Fig. S2) . It is worth noting that we did not find any HPV18-originated viral miRNAs in HVK-or HFK-derived raft cultures by miRNA-Seq.
HPV18 Regulates Host miRNA Expression over the Course of the Productive Infection. To validate the observation that the altered expression of host miRNAs is specifically attributable to HPV infection, HFK-derived raft cultures with HPV18 infection on day 8, day 10, day 12, and day 16 were analyzed by miRNA-Seq ( Fig. 2A) . Viral DNA amplification peaked on days 12-14, whereas viral oncoprotein expression waned (7) . Again, we did not detect any HPV18-originated viral miRNAs from the raft tissues at any of the four time points. However, relative to uninfected HFK raft cultures, the altered expression of host miRNAs was obvious and could be classified into four groups (Table S5) , with additional miRNAs showing fluctuations in expression over the time course (Dataset S1). The miRNAs in group 1 and group 2 exhibited increased and decreased expression over each of the time points. The miRNAs in group 3 displayed elevated expression in early HPV18 infection but reduced expression at the later time points, and the reverse was true for the miRNAs in group 4, which had decreased expression at the earlier time points but increased expression at the later time of HPV18 infection. Nine of the 13 miRNAs with altered expression in Table 1 were in group 1 and group 2 ( Fig. 2A and Table S5 ) and are selectively graphed in Fig. 2B to show their persistent increase or decrease over the course of HPV18 infection relative to the uninfected raft cultures. We also observed an initial increase, but later decrease, of miR-143, a p53-sensitive target (27, 28) and Ras responder (29) . In contrast, miR-203, a skin differentiation marker (30) , displayed an initial decrease but a stepwise increase in HFK raft tissues over the time course of HPV18 infection (Fig. 2B ), in agreement with the squamous differentiation achieved in these raft cultures (Fig. S3A ). Northern blotting confirmed the increased expression of miR-25 and miR-92a and the decreased expression of miR-27a and miR-29a in HFK-derived raft tissues on day 10 after HPV16 or HPV18 infection (Fig. 2C) . Together, these data suggest that the miRNAs in the first two groups respond consistently to HPV18 infection; however, the responses of the host miRNAs in group 3 and group 4 to HPV18 infection appear to be regulated by HPV activities (7) and keratinocyte differentiation, as reported (31, 32) . Based on these results and on the data shown in Fig. 1C and Table 1 , we subsequently chose eight host miRNAs (miR-16, miR-22, miR-25, miR-27a, miR-29a, miR-92a, miR-100, and miR-378) for further investigation. These miRNAs have high signal intensity or reads in all testing platforms ( Fig. S4 ) and are transcribed alone or in a larger cistron together with other miRNAs (cluster).
Host miRNAs and Oncogenic HPV E6 and E7. To investigate whether the increase or decrease of the eight miRNAs was regulated by viral oncoprotein E6 or E7, raft cultures derived from HFKs transduced with a retrovirus expressing HPV18 E6, HPV18 E7, HPV18 E6E7, or empty control retrovirus were examined by reverse transcription real-time quantitative PCR (RT-qPCR). U6 RNA was used as an internal loading control. miR-34a was used as a positive control for the E6 activity, which reduces miR-34a expression because this miRNA is regulated partially by p53 (18) . As expected, E6 decreased the expression of miR-34a, whereas E7 did not (18) . In contrast, HPV18 E7 significantly increased the expression of miR-25, whereas HPV18 E6 had no effect (Fig. 3 ). These observations validated the specificity of E6 and E7 activities. In addition, HPV18 E7 had a stronger positive effect than HPV18 E6 on the expression of miR-16 and miR-378, whereas both viral oncoproteins functioned similarly in inducing a moderate increase of miR-92a expression (Fig. 3) . Interestingly, miR-22, miR-27a, miR-29a, and miR-100 were all moderately down-regulated by either E6 or E7, with miR-22 and miR-27a being slightly more susceptible to E7 than to E6 (Fig. 3 ). These results demonstrate that this set of host miRNAs respond to HPV infection and their altered expression could be attributed to viral oncoprotein E6 or E7.
Expression of miR-16, miR-22, miR-25, miR-27a, miR-29a, miR-92a, miR-100, and miR-378 in HR HPV-Infected Cervical Lesions. To evaluate whether the altered expression of miRNAs in oncogenic HPV-infected raft tissues could be observed in CINs and CC infected with HR HPVs, we examined by RT-qPCR the expression of miR-16, miR-25, miR-92a, miR-378, miR-22, miR27a, miR-29a, and miR-100 in 38 normal cervical tissues without HPV infection and in 13 CIN1+2, 39 CIN3, and 68 CC tissues with HR HPV infection. As shown in Fig. 4A , statistically significant elevation of miR-25, miR-92a, and miR-378 was observed among HPV-infected tissue groups, consistent with the results obtained from HPV-infected raft tissues. Expression of miR-16 also displayed a trend of increase in CIN3 and CC tissues, but this increase might have been distorted by the extremely high levels of miR-16 in one sample in the CIN3 group and three samples in the CC group (Fig.  4A ). An increased level of miR-378 was observed in CIN3 (P = 0.021) and CC (P = 0.035) over the normal cervical tissues, but not in CC over CIN3 (P = 0.184). In contrast, we found no obvious change of miR-22, miR-27a, miR-29a, and miR-100 in CIN1+2 and CIN3 or of miR-22, miR-29a, and miR-100 in CC over the normal cervical tissues. However, a higher level of miR-27a was observed in CC compared with CIN3, CIN1+2, or normal cervical tissues. In this and previous studies (22) , miR-29a expression was decreased from normal tissue to CIN and CC, and this trend was verified by Northern blotting using RNAs extracted from a small group of randomly selected samples (Fig. S5) . However, this decrease was not statistically significant (P = 0.416) (Fig. 4A) .
Based on the mean values and statistical analysis, miR-25 and miR-92a were subsequently combined as a group; miR-22 and miR-29a were combined as another group; and the individual expression levels were averaged in each group for normal, CIN1+2, CIN3, and CC tissues. Comparison between two groups of miRNA levels showed a stepwise increase of the miR-25/92a from normal (1.6) to CIN1+2 (2.2), CIN3 (3.9), and CC (8.2) (Fig. 4B) , whereas the small fluctuation of miR-22/29a did not exhibit a trend. Given that individual miRNA levels varied from one sample to another, we further converted the miRNA expression level (Table S5 ) in HFK raft cultures over the course of HPV18 infection. (C) Verification of increased miR-25 and miR-92a expression and decreased miR-27a and miR-29a expression in the 10-d raft tissues derived from HFKs with or without HPV16 or HPV18 infection by Northern blot analysis. Three separate tissue samples labeled as 1, 2, and 3 in each raft tissue group were used for the assay. U6 RNA was used as a loading control. Bar graphs below the blot show the relative level (mean ± SD) of each miRNA, after being normalized to U6 RNA, from three separate raft tissues in each raft group.
from individual tissues to the expression ratio between miR-25/ 92a and miR-22/29a groups for a better view of the dataset. A threshold ratio was set at 1.5 to evaluate the possibility of using these four miRNAs for diagnosis of CINs and CC. As summarized in Table 2 , only 5 of 38 (13.2%) normal cervical tissues had a ratio equal to or higher than 1.5, but 5 of 13 CIN1+2 (38.5%), 19 of 39 CIN3 (48.7%), and 60 of 68 (88.2%) CC tissues had a ratio equal to or above 1.5 (P < 0.0001). This increase was significant even for CIN1+2 tissue samples compared with normal cervical samples (P = 0.047). Collectively, our data strongly suggest that the expression ratio between these two miRNA groups could be useful for the diagnosis of cervical lesions and progression to CC due to oncogenic HPV infections.
Discussion
In this report, host miRNAs specifically regulated by oncogenic HPV16 and HPV18 infection in HFK-and HVK-derived raft cultures were comprehensively investigated by both miRNA array analysis and miRNA-Seq. We identified 13 host miRNAs responsive to oncogenic HPV regulation, including nine miRNAs from six miRNA clusters (miR-15/16/195/457, miR-106b/93/25, miR-17-5p/18a/19a/20a/19b/92a, miR-224/452, miR-23a/24/27a, and miR-100/let-7a) and four noncluster miRNAs (miR-22, miR-29a, miR-210, and miR-378). The previously reported miRNAs (miR-21, miR-34a, miR-146a, miR-143/145, miR-203, and miR-218) that are altered in some CCs (21, 22, 33) or in HPV infection (18, 20, 34) are not among the 13 miRNAs identified in this study, nor are miRNAs altered in HPV31-infected HFK rafts (35) , because none of them were consistently altered in all four of our assay platforms. We note that HPV18 infection did modulate other cellular miRNAs in HFK rafts (Dataset S1), as previously found in HPV31 infection (35) . From the panel of 13 miRNAs, eight were selected to represent each cluster and noncluster miRNA for further investigation. The expression of miR-224 displayed fluctuation over the time course of HPV18 infection; thus, miR-224 was excluded from further study. miR-210 was also excluded because its expression is induced by hypoxia (36) and both HR and low-risk HPV E7 proteins enhance HIF-1α stability (37, 38) .
We note that miR-25, miR-27a, miR-92a, and miR-378 are oncogenic miRNAs and miR-16, miR-22, miR-29, and miR-100 are tumor-suppressive miRNAs (39) (40) (41) (42) and that they are modulated by p53, E2F, and c-Myc (25, (43) (44) (45) . Although miR-16, miR-25, and miR-92a from three different miRNA clusters and noncluster miR-378 all had increased expression, the expression of the miR106b/93/25 cluster produced from MCM7 transcript (46) appears to be the most sensitive to oncogenic HPV infection, with increased expression in each of the three miRNAs from this cluster in all assays (Table 1) . In contrast, miR-92a and miR-16 were the major miRNAs with significantly increased expression within the respective clusters of miR-17-5p/18a/19a/20a/19b/92a and miR-15/16.
We found that both viral E6 and E7 could enhance miR-92a expression but that only viral E7 was responsible for the up-regulation of miR-25 (Fig. 3) . These observations are consistent with our understanding that the expression of both the miR-106b/93/25 and miR-17-5p/18a/19a/20a/19b/92a clusters is suppressed by p53 through an indirect mechanism via inhibition of E2F1 expression (44, 47, 48) . Their up-regulation can then be attributed to the abilities of the HR HPV E6 to destabilize p53 and of the viral E7 to target the pRB/p130 protein family, resulting in the release of E2F from suppressive transcriptional complexes. Also, HR HPV E6 and E7 increase MCM7 expression through E2F-dependent and E2F-independent pathways (49), and c-Myc transactivated by E2F1 promotes transcription and expression of the miR-17-92a cluster (47) , as well as miR-378 (50) . Free E2F1 also transactivates the expression of the miR-15/16 cluster (51). Total RNAs were isolated from day 10 raft cultures of HFKs or HVKs. Thirteen miRNAs were identified by four test platforms (Fig. 1C ) that are altered in four HPV-infected raft cultures relative to control raft cultures. The numbers indicate the fold increase (+) or decrease (−) of the signal intensity [miRNA (miR)-array assay] or relative miRNA reads (miR-Seq) of the raft tissue with HPV infection divided by that of the raft tissue without HPV infection. Details are provided in Tables S1 and S2. Fig. 3 . HPV18 E6 and E7 oncoproteins regulate the expression of host miRNAs. Expressions of eight host miRNAs selected from Table 1 were examined by RT-qPCR in 11-d raft cultures of HFKs transduced with HPV18 E6, E7, or E6E7 retrovirus or an empty control retrovirus vector. miR-34a was used as a positive control for HPV18 E6 activity (18) , whereas U6 RNA was used as an internal loading control. The bar graph shows the relative fold increase (above 0) or decrease (below 0) (mean ± SD) of each miRNA in the raft tissues expressing E6, E7, or E6E7 over the empty vector after being normalized to U6 RNA from two independent experiments. (52, 53) . However, c-Myc suppresses the expression of many miRNAs (44) by binding to miRNA promoter, including those of miR-15/16, miR-23a/24/ 27a, miR-22, miR-29a, and miR-34a, for example (54-57). Moreover, c-Myc-induced miR-17-5p and miR-20a from the miR-17-92a cluster can inhibit E2F1 translation (43) and affect the expression of E2F1-dependent miRNAs (45, 58) . Our data indicate that the expression of oncogenic miRNAs is superimposed over that of the tumor-suppressive miRNAs as a net gain by HR HPV infection. It is possible that the posttranscriptional regulation could also play a role in this net gain, because p53 interacts with Drosha/p68 complex to facilitate Drosha-mediated primarymiRNA processing of certain miRNAs (27) and some miRNAs derived from intron regions are coupled to RNA splicing (59, 60) .
Both HR HPV E6 and E7 interact with c-Myc and augment c-Myc transactivation activities
We observed increased expression of miR-16, miR-25, miR92a, and miR-378 in CIN and CC tissues with HR HPV infection, consistent with what we observed in raft tissues with HPV16 or HPV18 infection. In particular, the striking increase of miR-25 and miR-92a correlated with the progression of the cervical lesions, making them credible biomarkers of CINs and CC. Furthermore, we found that the expression ratio of miR-25/ 92a vs. miR-22/29a increased even more significantly in CIN1+2 tissues over the normal cervical tissues as an early indicator of HPV infection of the cervix.
We note that the expression profiles of miR-22, miR-27a, miR-29a, and miR-100 in clinical samples are slightly different from those in HR HPV-infected and HPV18 oncogene-expressing raft cultures. Several reasons may account for the variation. First, the HPV-infected raft cultures have pathological changes similar to CIN1 only and maintain cell differentiation (Fig. S3A) . Cell differentiation could affect miRNA expression and, hence, the regulation of miRNAs in productive HPV infections (20, 25) . Indeed, the expression of miR-21, and presumably miR-27a and miR-205, in monolayer cell cultures was altered by cell differentiation in the presence of calcium (Fig. S3 B-D) . Second, raft cultures comprise a pure population of keratinocytes, whereas patient tissues contain many additional cell types, including fibroblasts, fat cells, endothelial cells, and infiltrating immune cells. Third, tissue sampling is another contributing factor, particularly for cervical precancer lesions, which are surrounded by normal tissues. The biopsies might be a mixture of normal and diseased tissues, thereby leading to a slightly different miRNA profile from sample to sample and from that of the raft cultures. An analysis of additional patient samples could help to clarify the conclusions. Also, because the sample sizes of CIN1+2 in our study are relatively small, future studies of additional and serial patient specimens over a period of time would be important to determine if there is an miRNA ratio conversion in correlation with CIN progression or regression.
Materials and Methods
Primary keratinocyte cultures and their derived raft tissues with or without HPV16 or HPV18 infection were prepared according to our standard protocols. Total RNA purified from raft tissues was used for miRNA microarray and miRNA-Seq analyses. The resultant miRNA profiles from each tissue were validated by Northern blotting and TaqMan miRNA RT-qPCR assays and were further verified in the institutional review board-approved human cervical tissues with or without HR HPV infections. A detailed discussion of the materials and methods used is provided in SI Materials and Methods. 
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SI Materials and Methods
Human Tissues, Raft Tissues, Keratinocyte Cultures, and RNA Preparation. Normal cervical, cervical intraepithelial neoplasia (CIN) grade 1-3, and cervical cancer (CC) tissues were obtained from anonymized excess cervical tissues, with informed consent, that were no longer needed for diagnosis or clinical purposes from a study approved for clinical research by the Institutional Review Board of the Zhejiang University Women's Hospital. CIN1-3 and CC tissues infected by high-risk human papillomaviruses (HPVs) and normal cervical tissues without HPV infection, as determined by Digene Hybrid Capture 2 High-Risk HPV DNA (Qiagen), were used in this study. Primary human foreskin keratinocytes (HFKs) and human vaginal keratinocytes (HVKs) maintaining HPV16 or HPV18 genomic DNA were cultured with epithelial (E) media in the presence of mitomycin C (4 μg/mL)-treated J2 3T3 feeder cells as previously described (1). The stratified and differentiated keratinocytes in the raft culture epidermal layer were collected free from collagen (no fibroblasts) on day 10 and frozen on dry ice for total cell RNA preparation. Additional productive HPV18 raft cultures of HFKs were obtained by Cre-loxP-mediated recombination as described (2), and the derived raft cultures were collected on day 8, day 10, day 12, and day 16 from one experiment. The epithelial tissue was homogenized in an Eppendorf tube in 1 mL of TRIzol Reagent (Invitrogen) using an electric homogenizer (Omni International) with a separate disposable probe. The isolated RNA was dissolved in RNase-free water and stored at −70°C for future use. HPV31 + CIN612 6E cells, which contain an integrated HPV31 genome and primary HFK, were cultured without feeder cells in keratinocyte serum-free medium (Invitrogen). CaCl 2 (2 mM) was added on the next day to promote differentiation. Total RNA and cellular protein were then prepared from the cells on day 3 or day 5 for CIN612 6E cells or on day 14 for HFKs with or without the addition of calcium.
Plasmid pLJd-HPV-18URR-E6E7 has been described (3). To construct pLJd-HPV-18URR-E6, pLJd-HPV-18URR-E6E7 was digested with NsiI, end-filled, and then partially digested with BamHI to release a BamHI-HPV18URR-E6 (6930-7857/1-589) fragment. The fragment was then inserted into pLJd between the BamH1 site and filled SalI site. HPV-18URR-E7 containing a long, untranslated leader sequence in the pLC vector (a derivative of pLJd) has been described (4). Retroviruses derived from the above vectors were prepared as described (5) . Primary HFKs were acutely infected with the retroviruses and selected for 2 d with G-418 at 300 μg/mL. The selected HFKs were used to establish epithelial raft cultures and harvested on day 11. Epithelial tissues were snap-frozen in liquid nitrogen and stored at −80°C until RNA extraction.
Micro-Paraflo MicroRNA Microarray Assay. Microarray assays were performed using a service provider (LC Sciences). The assay started with 5 μg of total RNA samples from HFK or HVK raft tissues with or without HPV16 or HPV18 infection. The RNA was size-fractionated using a YM-100 Microcon centrifugal filter (Sigma-Aldrich), and the 3′ ends of the small RNAs (<300 nt) were extended with a poly (A) tail using poly (A) polymerase. An oligonucleotide tag was then ligated to the poly (A) tail for subsequent detection with fluorescent dye; two different tags were used for the two RNA samples from different groups in dual-sample experiments. Hybridization was performed overnight on a micro-Paraflo microfluidic chip using a microcirculation pump. On the microfluidic chip, each detection probe consisted of a chemically modified nucleotide coding segment complementary to the target microRNA (miRNA) or other control RNAs and a spacer segment of polyethylene glycol to extend the coding segment away from the substrate. The detection probes were made by in situ synthesis using photogenerated reagent chemistry. The hybridization melting temperatures were balanced by chemical modifications of the detection probes. Hybridization was performed in 100 μL of 6× SSPE buffer [0.9 M NaCl, 60 mM Na 2 HPO 4, 6 mM EDTA (pH 6.8)] containing 25% (vol/vol) formamide at 34°C. After hybridization, the miRNAs were detected by fluorescence labeling using tag-specific Cy3 and Cy5 dyes. Hybridization images were collected using a laser scanner and digitized using Array-Pro image analysis software (Media Cybernetics). Data were analyzed by first subtracting the background and then normalizing the signals using a locally weighted regression filter. For two-color experiments, the ratio of the two sets of detected signals (log 2 -transformed and balanced) was calculated, and the significance of the differences was determined by t test analysis; significantly different signals were those with P values less than 0.05.
Northern Blotting of miRNAs. Total RNA from raft tissues (30 μg) or clinical tissues (20 μg) was resolved on a 15% denaturing polyacrylamide gel and transferred onto a GeneScreen-Plus Hybridization Transfer Membrane (PerkinElmer) in 0.5× TBE (Tris-borate-EDTA) buffer as described (6, 7) . The membrane was prehybridized with PerfectHyb plus Hybridization buffer (Sigma) for 2 h and then blotted with Gamma-32 P-labeled miRNAspecific antisense probe overnight at 42°C. The membrane was washed sequentially in 50 mL of 2× SSPE buffer containing 0.5% SDS, 0.5× SSPE buffer containing 0.5% SDS, and 0.2× SSPE buffer containing 0.1% SDS for 30 min each at 42°C and was then exposed to a PhosphorImager screen (Molecular Dynamics). The image was captured using a Molecular Dynamics PhosphorImager Storm 860 and analyzed with ImageQuant software. After blotting, the same membrane was stripped in 0.1% SSPE buffer and 0.5% SDS at 90°C, prehybridized with hybridization buffer for 2 h, and then hybridized with another probe overnight at 42°C. The antisense oligodeoxynucleotide probes were designed based on individual miRNA sequences deposited in miRBase (www. mirbase.org). An antisense oligo of U6 snRNA (5′-AAAATAT-GGAACGCTTCACGA-3′) was used to detect U6 snRNA from each sample as a loading control.
TaqMan MicroRNA Real-Time Quantitative PCR Assays. Quantitative expression of miRNAs in raft tissues and clinical samples was analyzed by real-time PCR TaqMan MicroRNA Assays (Applied Biosystems) as described (8, 9) . In brief, 10 ng of total RNAs from each tissue was used per reverse transcription reaction (16°C for 30 min, 42°C for 30 min, 85°C for 5 min, and hold at 4°C) to synthesize single-stranded cDNA using the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems) according to the procedures described by the manufacturer. After reverse transcription, PCR products were amplified from cDNA samples using the TaqMan MicroRNA Assays together with TaqMan Universal PCR Master Mix (Applied Biosystems) using a StepOne Plus Real-Time PCR System (Applied Biosystems). To avoid interplate variability, miRNA expression analyses were performed using a single 96-well plate in duplicate. U6 RNA was used as an internal control and analyzed in the same plate for each sample. Each threshold cycle (Ct) value of real-time quantitative PCR data from two repeats was individually normalized to U6 RNA and analyzed by the 2 -ΔΔCt method (10) . The mean Ct value of a given miRNA from 38 normal cervical tissues after normalization served as a basal level to calculate a relative level of the miRNA detected in each clinical sample. The data were then presented as bar graphs with mean ± SD. The significance of the miRNA levels among three clinical tissue groups was analyzed using a Student t test, χ 2 test, or Fisher's exact test.
miRNA-Sequencing. Barcoded small RNA cDNA libraries from HPV-infected and uninfected raft tissue samples were prepared as described previously (11) . Identification of miRNAs and other small regulatory RNAs was undertaken using cDNA library sequencing (11) . Two micrograms of total RNA was ligated to 100 pmol of adenylated 3′ adapter containing a unique sequence at its 5′ end in a 20-μL reaction volume using 1 μg of Rnl2(1-249) K227Q (plasmid for expression of recombinant ligase is available at www.addgene.org) in 50 mM Tris·HCl (pH 7.6), 10 mM MgCl 2 , 10 mM 2-mercaptoethanol, 0.1 mg/mL acetylated BSA (Sigma), and 15% DMSO, and was incubated for 16 h on ice.
Following 3′ adapter ligation, the products were purified on a 15% denaturing polyacrylamide gel and small RNAs, measuring 45-50 nt in length, were recovered and ligated to 100 pmol of 5′ oligoribonucleotide adapter (GUUCAGAGUUCUACAGUC-CGACGAUC) in a 20-μL reaction volume using 1 μg of Rnl1 RNA ligase in 50 mM Tris·HCL (pH 7.6), 10 mM MgCl 2 , 10 mM 2-mercaptoethanol, 0.2 mg/mL acetylated BSA, 0.1 mg/mL acetylated BSA, 0.2 mM ATP, and 15% DMSO, and were incubated for 1 h at 37°C. Ligated small RNAs were purified on a 12% polyacrylamide gel, reverse-transcribed using SuperScript III Reverse Transcriptase (Invitrogen), and amplified by two rounds PCR using appropriate primers (reverse transcription PCR primer was CAAGCAGAAGACGGCATACGA, and forward PCR primer was AATGATACGGCGACCACCGACAG-GTTCAGAGTTCTACAGTCCGA). All libraries were sequenced using an Illumina HiSeq sequencing system. Alignment and annotation were performed as previously described (11) (www. sciencedirect.com/science/article/pii/S1046202312001764). Fig. S1 . Analysis of representative miRNA array chips. The images are displayed in pseudocolors so as to expand the visual dynamic range. In the Cy3 and Cy5 intensity images, as signal intensity increases from 1 to 65,535, the corresponding color changes from blue to green, to yellow, and to red. In the Cy3/Cy5 ratio image, when the Cy3 level is higher than the Cy5 level the color is green; when the Cy3 level is equal to the Cy5 level, the color is yellow; and when the Cy5 level is higher than the Cy3 level, the color is orange/red. The numbers in each image are the corresponding miRNAs. . Eight abundant miRNAs were selected for further investigation based on multiple comparisons (Fig. 1C and Table 1 ). Various comparisons between different cells, different viruses, and different methods consistently identified up-regulation of miR-16, miR-25, miR-92a, and miR-378 and down-regulation of miR-22, miR-27a, miR-29a, and miR-100 by HPV16 or HPV18 infection. The numbers stand for the signal intensity (miRNA array) of each miRNA or miRNA read (miRNA-Seq) from different rafts with or without HPV16 or HPV18 infection. 
